Cargando…
MDSC in Mice and Men: Mechanisms of Immunosuppression in Cancer
Myeloid-derived suppressor cells (MDSCs) expand during pathological conditions in both humans and mice and their presence is linked to poor clinical outcomes for cancer patients. Studying MDSC immunosuppression is restricted by MDSCs’ rarity, short lifespan, heterogeneity, poor viability after freez...
Autores principales: | Vanhaver, Christophe, van der Bruggen, Pierre, Bruger, Annika M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268873/ https://www.ncbi.nlm.nih.gov/pubmed/34203451 http://dx.doi.org/10.3390/jcm10132872 |
Ejemplares similares
-
Immunosuppressive low-density neutrophils in the blood of cancer patients display a mature phenotype
por: Vanhaver, Christophe, et al.
Publicado: (2023) -
Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma
por: Gondois-Rey, Françoise, et al.
Publicado: (2021) -
Critical immunosuppressive effect of MDSC-derived exosomes in the tumor microenvironment
por: Rashid, Mohammad H., et al.
Publicado: (2021) -
Long non-coding RNA RUNXOR accelerates MDSC-mediated immunosuppression in lung cancer
por: Tian, Xinyu, et al.
Publicado: (2018) -
STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice
por: Bitsch, Rebekka, et al.
Publicado: (2022)